SCHEMBL3797646

SCHEMBL3797646

NC(=O)C1(c2nccs2)CCC1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.35
LMNA P02545 3/20 0.35
OPRL1 P41146 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
TSHR P16473 4/20 0.33
NOS1 P29475 1/20 0.33
HSD17B10 Q99714 1/20 0.33
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
POLB P06746 1/20 0.32
HTT P42858 1/20 0.32
HPGD P15428 1/20 0.32
EPHX2 P34913 1/20 0.32
KDM4E B2RXH2 1/20 0.32
EEF2K O00418 2/20 0.32
GRM5 P41594 1/20 0.31
GRM1 Q13255 1/20 0.31
RBBP9 O75884 1/20 0.31
DPP4 P27487 1/20 0.31
DPP8 Q6V1X1 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2053963 0.97 LMNA (0.36) ALDH1A1LMNAOPRL1L3MBTL1TSHR
SCHEMBL2016931 0.95 LMNA (0.38) ALDH1A1LMNAOPRL1L3MBTL1TSHR
SCHEMBL2040851 0.93 LMNA (0.39) ALDH1A1LMNAOPRL1L3MBTL1TSHR
SCHEMBL2037379 0.87 PDE4A (0.34) ALDH1A1LMNAOPRL1L3MBTL1TSHR
SCHEMBL28088924 0.81 CNR2 (0.38) ALDH1A1LMNAOPRL1L3MBTL1TSHR
SCHEMBL2035833 0.79 AKR1C1 (0.42) ALDH1A1LMNAOPRL1L3MBTL1TSHR
SCHEMBL2037649 0.79 AKR1C1 (0.42) ALDH1A1LMNAOPRL1L3MBTL1TSHR
SCHEMBL30627157 0.79 CYP3A4 (0.38) ALDH1A1LMNAL3MBTL1TSHRMEN1
SCHEMBL2035761 0.77 OPRL1 (0.40) ALDH1A1LMNAOPRL1L3MBTL1TSHR
SCHEMBL30627103 0.74 CYP3A4 (0.37) ALDH1A1LMNAL3MBTL1TSHRMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010118208-A1 BENZOXAZEPIN-4- (5H) -YL DERIVATIVES AND THEIR USE TO TREAT CANCER EXELIXIS, INC. (US) 2010-10-14 WO disclosed